Earnings Recap

AKZA.AS Akzo Nobel Earnings: April 2026 Recap

April 22, 2026
5 min read

Akzo Nobel N.V. (AKZA.AS) released its latest earnings on April 21, 2026, marking another important milestone for the Amsterdam-based specialty chemicals giant. The company, which produces paints and coatings under brands like Dulux and International, continues to navigate a complex market environment. With a market cap of €8.93 billion and 341,000 employees worldwide, Akzo Nobel remains a key player in the global coatings industry. Meyka AI rates AKZA.AS with a grade of B+, reflecting mixed fundamentals and growth prospects. Investors are closely watching how the company performs amid ongoing economic pressures and shifting demand patterns.

Financial Performance and Earnings Results

Akzo Nobel’s latest earnings report shows the company navigating mixed financial conditions. The company reported an EPS of €3.70 based on trailing twelve-month data, with a PE ratio of 14.11 indicating moderate valuation relative to peers. Revenue per share reached €59.37 TTM, demonstrating the company’s substantial sales base across its global operations.

Operating Margins Under Pressure

The company’s operating profit margin stands at 7.62% TTM, reflecting ongoing cost pressures in the specialty chemicals sector. Net profit margin of 6.25% shows the company retains reasonable profitability despite headwinds. Operating income declined 15.59% year-over-year, signaling challenges in operational efficiency and market conditions.

Cash Flow Strength

Operating cash flow per share reached €5.35 TTM, while free cash flow per share came in at €3.54. The company generated €1.98 in dividends per share, maintaining its commitment to shareholders. Free cash flow growth surged 67.4% year-over-year, a bright spot indicating improved working capital management and operational efficiency gains.

Akzo Nobel’s growth metrics reveal a company in transition, with some segments improving while others face headwinds. Net income growth of 17.16% year-over-year demonstrates improved bottom-line performance despite revenue challenges. EPS growth of 17.03% outpaced net income growth, benefiting from modest share count reductions.

Revenue Headwinds

Revenue declined 5.16% year-over-year, reflecting weak demand in key markets and pricing pressures. Gross profit fell 6.64%, indicating margin compression from raw material costs and competitive pricing. However, EBIT grew 13.23%, showing management’s ability to control operating expenses and improve operational leverage.

Three-Year Momentum

Over three years, net income per share grew 84.34%, reflecting significant profitability improvements. Operating cash flow per share surged 221.3% over three years, demonstrating substantial cash generation improvements. These longer-term trends suggest the company has successfully restructured operations and improved capital efficiency.

Valuation and Market Position

At €53.54 per share, Akzo Nobel trades at a reasonable valuation relative to its fundamentals and industry peers. The price-to-sales ratio of 0.88 suggests the stock trades below historical averages, potentially offering value. The PE ratio of 14.11 sits below the broader market, indicating investors are pricing in slower growth expectations.

Dividend Yield and Shareholder Returns

The company offers a dividend yield of 3.79%, providing attractive income for long-term holders. Payout ratio of 55.28% leaves room for dividend growth or reinvestment in the business. The stock has gained 0.45% recently, with volume reaching 942,594 shares, above the 738,392 average.

Technical Position

The RSI of 50.85 indicates neutral momentum, neither overbought nor oversold. The stock trades within Bollinger Bands (upper: €54.06, lower: €47.34), suggesting normal volatility. ADX of 27.39 shows a strong trend in place, though direction remains uncertain given neutral RSI readings.

What Investors Should Know

Akzo Nobel’s earnings reflect a company managing through industry challenges while maintaining profitability and cash generation. The B+ rating from Meyka AI acknowledges both strengths and concerns in the current environment. Strong cash flow generation and improving net income contrast with revenue declines and margin pressures.

Debt and Financial Health

Debt-to-equity ratio of 1.04 indicates moderate leverage, manageable but worth monitoring. Interest coverage of 4.16x provides adequate cushion for debt service. The company maintains a current ratio of 1.44, showing solid short-term liquidity for operations and obligations.

Forward Outlook

Three-year forecasts suggest stock prices may face headwinds, with projections declining to €43.38 in three years. However, the company’s strong cash generation and dividend support provide downside protection. Investors should monitor demand trends in decorative and performance coatings markets closely.

Final Thoughts

Akzo Nobel’s April 2026 results show strong cash flow and earnings growth despite a 5.16% revenue decline, earning a B+ Meyka AI rating. At €53.54 with a 3.79% dividend yield, the stock appeals to income investors seeking value. However, margin compression and limited growth prospects warrant caution. The company demonstrates operational excellence in improving profitability amid revenue pressures, but investors should await market stabilization signals before expecting significant upside.

FAQs

Did Akzo Nobel beat or miss earnings estimates?

Specific estimates unavailable. Akzo Nobel reported €3.70 EPS TTM with 17.03% year-over-year growth, demonstrating strong bottom-line improvement despite a 5.16% revenue decline.

What is Meyka AI’s rating for AKZA.AS?

Meyka AI assigns a B+ grade, indicating neutral recommendation. Strong DCF and ROA scores are balanced against concerns regarding debt levels and valuation metrics.

How is Akzo Nobel’s dividend?

Akzo Nobel offers 3.79% dividend yield at €1.98 per share annually. The 55.28% payout ratio allows growth room, supported by strong cash flow generation.

What are the main challenges for Akzo Nobel?

Revenue declined 5.16% year-over-year from weak demand and pricing pressures. Gross profit fell 6.64%, indicating margin compression. Operating income dropped 15.59%, reflecting sector-wide operational challenges.

Is AKZA.AS a good buy at current prices?

At €53.54, AKZA.AS trades at reasonable valuation with PE 14.11 and price-to-sales 0.88. The B+ rating suggests neutral stance. Strong cash flow and dividend appeal to income investors.

Disclaimer:

Stock markets involve risks. This content is for informational purposes only. Earnings estimates are analyst projections and not guarantees of actual results. Past performance does not guarantee future results. Meyka AI PTY LTD provides market analysis and data insights, not financial advice. Always conduct your own research and consider consulting a licensed financial advisor.

What brings you to Meyka?

Pick what interests you most and we will get you started.

I'm here to read news

Find more articles like this one

I'm here to research stocks

Ask Meyka Analyst about any stock

I'm here to track my Portfolio

Get daily updates and alerts (coming March 2026)